Groote Schuur Hospital is the first hospital in Middle East, Africa, Central Asia, and Turkey to recently implant the world’s smallest pacemaker: the Medtronic Micra™ Transcatheter Pacing System (TPS). The device was implanted as part of the Medtronic global pivotal clinical trial.
Comparable in size to a large vitamin
One-tenth the size of a conventional pacemaker, and comparable in size to a large vitamin, the Micra TPS pacemaker is delivered directly into the heart through a catheter inserted in the femoral vein.
Once positioned, the pacemaker is securely attached to the heart wall and can be repositioned if needed. The miniature device does not require the use of wires, known as “leads,” to connect to the heart.
Read: Heart attack
Attached to the heart via small tines, the pacemaker delivers electrical impulses that pace the heart through an electrode at the end of the device.
“This miniaturized technology is designed to provide patients with the advanced pacing technology of traditional pacemakers via a minimally invasive approach,” said Dr. Ashley Chin, Consultant Cardiologist/Electrophysiologist at Groote Schuur Hospital and the University of Cape Town, who implanted the first Micra transcatheter pacemaker in Middle East, Africa, Central Asia, and Turkey.
Selected among an elite group
“We are proud that Groote Schuur Hospital was selected among an elite group of institutions to take part in this global clinical trial. If positive, the results of the trial could potentially benefit the more than one million people globally who receive pacemakers each year.”
In contrast to current pacemaker implant procedures, the Micra TPS implant does not require a surgical incision in the chest and the creation of a “pocket” under the skin.
This eliminates a potential source of complications, and any visible sign of the device. The Medtronic Micra TPS is an investigational device worldwide.
New cholesterol drugs may cut heart attack risk by half
How drinking can be good for your heart
Shorter people have bigger risk of heart disease